LU88346I2 - Torasemide (Exhydran) - Google Patents

Torasemide (Exhydran)

Info

Publication number
LU88346I2
LU88346I2 LU88346C LU88346C LU88346I2 LU 88346 I2 LU88346 I2 LU 88346I2 LU 88346 C LU88346 C LU 88346C LU 88346 C LU88346 C LU 88346C LU 88346 I2 LU88346 I2 LU 88346I2
Authority
LU
Luxembourg
Prior art keywords
exhydran
torasemide
Prior art date
Application number
LU88346C
Other languages
English (en)
Original Assignee
Christiaens Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christiaens Sa A filed Critical Christiaens Sa A
Publication of LU88346I2 publication Critical patent/LU88346I2/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU88346C 1974-04-17 1993-06-30 Torasemide (Exhydran) LU88346I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1683674A GB1477664A (en) 1974-04-17 1974-04-17 Pyridine derivatives
YU1507/81A YU42409B (en) 1974-04-17 1981-06-15 Process for obtaining new pyridine derivatives

Publications (1)

Publication Number Publication Date
LU88346I2 true LU88346I2 (fr) 1994-05-04

Family

ID=26252269

Family Applications (2)

Application Number Title Priority Date Filing Date
LU72284A LU72284A1 (fr) 1974-04-17 1975-04-15
LU88346C LU88346I2 (fr) 1974-04-17 1993-06-30 Torasemide (Exhydran)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU72284A LU72284A1 (fr) 1974-04-17 1975-04-15

Country Status (19)

Country Link
US (2) US4018929A (fr)
JP (1) JPS5951536B2 (fr)
AR (4) AR211097A1 (fr)
AT (1) AT344170B (fr)
BE (1) BE827844A (fr)
CA (1) CA1070313A (fr)
CH (3) CH609045A5 (fr)
DD (2) DD121936A5 (fr)
DE (1) DE2516025A1 (fr)
ES (4) ES436581A1 (fr)
FR (1) FR2267775B1 (fr)
GB (1) GB1477664A (fr)
HU (1) HU171420B (fr)
IL (1) IL47084A (fr)
LU (2) LU72284A1 (fr)
NL (2) NL183580C (fr)
SE (2) SE424320B (fr)
YU (1) YU42409B (fr)
ZA (1) ZA752243B (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
US4776878A (en) * 1978-12-04 1988-10-11 E. I. Du Pont De Nemours And Company Agricultural pyridinesulfonamides
LU85193A1 (fr) * 1984-01-31 1985-09-12 Christiaens Sa A Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
US4853389A (en) * 1987-07-24 1989-08-01 American Home Products Corporation Diuretic and antihypertensive substituted-5-pyrimidinesulfonylureas
US4914203A (en) * 1987-07-24 1990-04-03 American Home Products Corporation 5 step process for preparing certain 2,4-diamino-5-pyrimidine-sulfonyl ureas
FR2659080B1 (fr) * 1990-03-02 1994-07-08 Adir Nouveaux derives de la pyridylsulfonyluree et de la pyridylsulfonylthiouree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5166162A (en) * 1990-03-02 1992-11-24 Adir Et Compagnie Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
US5486530A (en) * 1991-04-27 1996-01-23 Boehringer Mannheim Gmbh Use of torasemide for the treatment of brain oedemas
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US6166045A (en) * 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
WO2001010441A1 (fr) * 1999-08-11 2001-02-15 Teva Pharmaceutical Industries Ltd. Polymorphes de torsemide
HUP0600143A2 (en) * 2000-02-17 2006-10-28 Teva Pharma A stable pharmaceutical formulation comprising torsemide modification ii
HRP20000162B1 (en) * 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
NZ521852A (en) 2000-03-20 2004-10-29 Teva Pharma Novel processes for preparing torsemide intermediate
EP1741429A3 (fr) * 2000-03-20 2007-01-17 Teva Pharmaceutical Industries Ltd. Procédé pour la préparation de torsemide
HRP20000328A2 (en) * 2000-05-19 2002-02-28 Pliva Farmaceutska Ind Dionik Novel polymorph v of torasemide
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
IN192178B (fr) 2001-08-03 2004-03-06 Ranbaxy Lab
IL149771A0 (en) * 2002-05-21 2002-11-10 Fintech Lab Ltd Process for preparation of torsemide
HRP20020603B1 (en) * 2002-07-19 2008-11-30 Pliva D.D. New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
CA2401546C (fr) * 2002-09-06 2006-09-19 Brantford Chemicals Inc. Synthese de derives de la 3-sulfonamido-4-phenylaminopyridine
ITMI20022749A1 (it) * 2002-12-23 2004-06-24 Cosma S P A Nuovo procedimento per la sintesi della tosemide, in particolare della forma ii pura e stabile.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20050215600A1 (en) * 2003-10-27 2005-09-29 Arie Gutman Polymorphs of torsemide hydrochloride and process for production thereof
US7378527B2 (en) * 2004-03-16 2008-05-27 Daqing Che Process for the preparation of torsemide and related intermediates
US20070149526A1 (en) * 2005-10-17 2007-06-28 Neurotherapeutics Pharma, L.L.C. Diuretic and diuretic-like compound analogs
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7625896B2 (en) * 2005-11-25 2009-12-01 Hoffman-La Roche Inc. Pyridylsulfonamide derivatives
US7939532B2 (en) * 2006-10-26 2011-05-10 Hoffmann-La Roche Inc. Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2008138594A1 (fr) * 2007-05-16 2008-11-20 F. Hoffmann-La Roche Ag Dérivés d'aryl pyridyl sulfonamide, leur fabrication et leur utilisation en tant qu'agents pharmaceutiques
NL2006622C2 (en) 2011-04-18 2012-10-22 Eurovet Animal Health B V Use of a composition comprising torasemide.
EP2887806B1 (fr) 2012-07-20 2019-11-13 University Of Rochester Méthode de traitement et de prévention d'une atteinte cérébrale faisant appel à des inhibiteurs de l'isoforme 1 du cotransporteur na+-k+ -2ci
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
MY193765A (en) * 2015-02-16 2022-10-27 Univ Queensland Sulfonylureas and related compounds and use of same
HRP20220195T1 (hr) 2017-07-07 2022-04-15 Inflazome Limited Novi spojevi sulfonamid karboksamida
RS66416B1 (sr) 2019-01-18 2025-02-28 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i metode njegove primene
WO2021171230A1 (fr) * 2020-02-28 2021-09-02 Cadila Healthcare Limited Nouveaux dérivés de sulfonylurées et de sulfoximineurées substitués

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674794A (en) * 1970-03-18 1972-07-04 Ciba Geigy Corp Certain-3-pyridine-sulfonamide derivatives
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
GB1414793A (en) * 1972-07-28 1975-11-19 Manuf Prod Pharma Derivatives of phenylaminopyridine
US3904636A (en) * 1971-11-09 1975-09-09 Christiaens Sa A 3-sulfonamido-4-phenyl aminopyridines and derivatives

Also Published As

Publication number Publication date
HU171420B (hu) 1978-01-28
CH610890A5 (fr) 1979-05-15
ES453328A1 (es) 1977-11-01
NL940014I2 (nl) 1997-04-01
JPS5951536B2 (ja) 1984-12-14
NL7504521A (nl) 1975-10-21
ES453327A1 (es) 1977-11-16
IL47084A (en) 1979-01-31
SE7504409L (sv) 1975-10-20
YU150781A (en) 1984-02-29
JPS50142571A (fr) 1975-11-17
IL47084A0 (en) 1975-06-25
CA1070313A (fr) 1980-01-22
SE424320B (sv) 1982-07-12
CH609045A5 (fr) 1979-02-15
BE827844A (fr) 1975-10-13
DD121936A5 (fr) 1976-09-05
YU42409B (en) 1988-08-31
CH612424A5 (fr) 1979-07-31
ES436581A1 (es) 1977-04-01
NL940014I1 (nl) 1994-09-16
AT344170B (de) 1978-07-10
DD126887A5 (fr) 1977-08-17
USRE30633E (en) 1981-06-02
AR208768A1 (es) 1977-02-28
AR208770A1 (es) 1977-02-28
SE7907618L (sv) 1979-09-13
AR208769A1 (es) 1977-02-28
US4018929A (en) 1977-04-19
NL183580B (nl) 1988-07-01
ATA288275A (de) 1977-11-15
ES453329A1 (es) 1977-11-16
LU72284A1 (fr) 1975-08-20
FR2267775A1 (fr) 1975-11-14
FR2267775B1 (fr) 1978-11-10
AU8001675A (en) 1976-10-14
DE2516025C2 (fr) 1988-11-03
DE2516025A1 (de) 1975-11-06
NL183580C (nl) 1988-12-01
AR211097A1 (es) 1977-10-31
GB1477664A (en) 1977-06-22
ZA752243B (en) 1976-03-31

Similar Documents

Publication Publication Date Title
LU88346I2 (fr) Torasemide (Exhydran)
DK198075A (da) Planetgear
BE834318A (fr) Ophanginrichting
FI54981C (fi) Regleringssystem foer traktor
DK261175A (da) Ridesadel
DK577775A (da) Pigdek
AT338077B (de) Handmuhle
DK319075A (da) Parkometer
AT345679B (de) Kettenschloss
HU172312B (hu) Mekhanizm k litejnym ustrojstvam dlja vyvoda zhidkikh metallov
FI54847B (fi) Ransoneringsbehaollare foer djurutfodringsanordningar
DK281175A (da) Substituerede 0-acyl-acrylaldoximer
DK234275A (da) Harkroller
DK303375A (da) Skyderist
DK139405C (da) Klapankerrelae
BE824358R (fr) Phenolethanolamine acylff
AT342532B (de) Sparkerze
FI53479C (fi) Stomme foer vaeggelement
BE826873A (fr) Alkylsulfonylphenoxypropanolamines
BE825385A (fr) Elektrofotografisch filmdeel
JPS5173034A (ja) Tainetsuseisetsuchakuzaisoseibutsu
FI54848B (fi) Fiskekrok
DK203575A (da) Substituerede alfa-carboxyacetamid
DK138767B (da) Skyderist
JPS5158869A (ja) Bannaihandotaisoshinoreikyakuhoshiki